QualityStocksNewsBreaks Archives - Page 4 of 1515

TuesdayMar 10, 2026 9:00 am

QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) SGX945 Granted Promising Innovative Medicine Designation in UK for Behçet Disease

Soligenix (NASDAQ: SNGX) announced that SGX945 (dusquetide) has received Promising Innovative Medicine (“PIM”) designation from the U.K. Medicines and Healthcare Products Regulatory Agency for the treatment of Behçet’s Disease. The designation represents the first step toward potential inclusion in the U.K.’s Early Access to Medicines Scheme, which allows patients with life-threatening or seriously debilitating conditions to access promising therapies earlier. The PIM designation was granted based on Phase 2 clinical data indicating that dusquetide may provide a significant advantage over existing treatments while demonstrating a favorable potential benefit-risk profile for patients with this rare inflammatory disorder. To view the full…

MondayMar 09, 2026 9:55 am

QualityStocksNewsBreaks – Octane Announces Neuro Tech Forum 2026 to Be Held March 26-27 in Newport Beach

Octane announced that the Octane Neuro Tech Forum 2026 will take place March 26-27, 2026, at VEA Newport Beach, A Marriott Resort & Spa in Newport Beach, California, bringing together industry leaders, clinicians, investors and entrepreneurs to advance innovation in neurotechnology. The event, part of Octane’s Innovation Event Series, will feature keynote speaker Dr. Adnan Siddiqui, CEO and CMO of the Jacobs Institute, along with more than 30 expert speakers addressing emerging neurotech technologies, digital health innovation, brain-computer interfaces and the evolving investment landscape. The forum will include innovation panels, investor-focused sessions, company presentations and networking opportunities designed to foster…

MondayMar 09, 2026 9:40 am

QualityStocksNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS) Announces 1-for-3 Reverse Share Split to Maintain Nasdaq Listing Compliance

Wearable Devices (NASDAQ: WLDS), a technology growth company specializing in artificial intelligence-powered touchless sensing wearables, announced it will implement a one-for-three reverse split of its ordinary shares and tradable warrants, effective when trading begins on a split-adjusted basis on March 11, 2026. The action is intended to increase the company’s per-share trading price to regain compliance with the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market. Following the reverse split, the number of issued and outstanding ordinary shares will be reduced from 10,593,227 to approximately 3,531,076, while publicly held warrants will decrease from 98,589 to about 32,863, with…

MondayMar 09, 2026 9:20 am

QualityStocksNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Establishes Operational Environment for Ukraine Field Testing of Overwatch Platform

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) announced that it has established the operational environment for its Overwatch GPS-denied navigation and targeting platform for the Ukraine market and expects to deliver the system this week as part of operational field testing first announced in February 2026. The testing will evaluate the platform’s navigation and target acquisition capabilities under persistent GPS jamming and degraded signal conditions, providing a key validation milestone for defense and security applications in contested environments. In conjunction with the deployment,…

MondayMar 09, 2026 9:10 am

QualityStocksNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics Opens Palm Beach Clinic for Depression and PTSD Treatment

NRx Pharmaceuticals (NASDAQ: NRXP) announced that its subsidiary HOPE Therapeutics has opened a new clinic in Palm Beach, Florida, focused on treating depression and post-traumatic stress disorder through an interventional psychiatry approach that includes ketamine and other neuroplastic drugs, transcranial magnetic stimulation (TMS), hyperbaric oxygen therapy and physician-led psychotherapy. The facility expands HOPE’s growing network of clinics and builds on a nationwide partnership with neurocare AG to bring non-invasive neuroplastic therapies to patients. Peer-reviewed publications cited by the company report an 87% clinical response rate in treatment-resistant depression using short-term treatment protocols, while pilot programs incorporating hyperbaric oxygen therapy have…

MondayMar 09, 2026 9:00 am

QualityStocksNewsBreaks – Silvercorp Metals Inc. (TSX: SVM) (NYSE American: SVM) Files Updated Mineral Resource Estimate for Kyrgyzstan Gold Projects

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising. Silvercorp Metals (TSX: SVM) (NYSE American: SVM) announced the filing of an updated Mineral Resource Estimate for the Tulkubash and Kyzyltash Chaarat Gold Projects in the Republic of Kyrgyzstan through a National Instrument 43-101 technical report titled “NI 43-101 Technical Report and Updated Mineral Resource Estimate for the Tulkubash And Kyzyltash Chaarat Gold Project Republic Of Kyrgyzstan,” effective Oct. 15, 2025. The report was prepared in accordance with Canadian Securities Administrators’ National Instrument 43-101 – Standards of Disclosure for Mineral Projects and is available on…

FridayMar 06, 2026 3:31 pm

QualityStocksNewsBreaks – CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) Advances Exploration Strategy at Flagship Idaho Silver Project

Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) and may include paid advertising. CMX (CSE: CXC) (OTC: CXXMF), an exploration-stage company advancing the historic Clayton Silver Mine in Idaho, is on track to execute a plan this spring for a comprehensive geophysical program at its flagship plant. An article discussing this reads, “The comprehensive geophysical program will include a 3-D Direct Current Induced Polarization (‘DCIP’) survey and a Magnetotelluric (‘MT’) survey to delineate known structures on the property. In addition, this program will work to identify the extensions of the partially mined ore body, identify potential new ore bodies, and evaluate deeper sources of…

FridayMar 06, 2026 3:13 pm

QualityStocksNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Adds Innovative LiGHT Therapy to Pipeline

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, recently acquired Liora Technologies, which is pioneering proton therapy systems for treating tumors in various types of cancers. “Liora is becoming a wholly owned subsidiary of LIXTE, and the acquisition also includes Liora’s proprietary flagship technology, the LiGHT System (Linac for Image Guided Hadron Therapy), which offers many advantages over other technologies that are currently available for treating tumors with proton therapy,” reads an article discussing the move. “The highly adaptable LiGHT System provides a proton beam allowing the delivery of very high dose rates to deep-seated tumors,” said Professor Steve Myers, the former Director of Accelerators and Technology…

FridayMar 06, 2026 2:55 pm

QualityStocksNewsBreaks – Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Highlights $35M Program to Advance Alaska’s Upper Kobuk Mineral Projects

Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ)  and may include paid advertising. Trilogy Metals (NYSE American: TMQ) (TSX: TMQ), a mine development and exploration company, recently received an investment from the US federal government to advance both the exploration and development of the Upper Kobuk Mineral Projects in the northwestern part of Alaska. “These projects are held by Ambler Metals LLC, which is Trilogy’s 50/50 joint venture with South32 Limited,” reads a recent article. “Thanks to the investment, the company is strengthening both the advisory and leadership teams to drive project execution and deliver more…

FridayMar 06, 2026 2:45 pm

QualityStocksNewsBreaks – Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) Eyes Opportunity at the Intersection of Geology and Geopolitics

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising. Canamera Energy Metals (CSE: EMET) (OTCQB: EMETF) is strategically positioning as a top exploration company focused on critical metals and rare elements that are increasingly important to modern economies. “With the global increase in demand for materials essential for electrification, clean energy technologies, defense systems, and advanced manufacturing, Canamera is at the forefront of a portfolio-driven strategy aimed at identifying and leveraging district-scale opportunities in America,” reads a recent article. “The company’s exploration focus highlights the rapidly evolving dynamics of the global supply…

Site Search

Company Search

Category: QualityStocksNewsBreaks